Replacing one serving of sugary drink every day may lower diabetes risk
the ONA take:
According to research published in the journal Diabetologia, researchers have found that replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes by 14 to 25%.
Specifically, researchers found that replacing a serving of a soft drink with water, unsweetened tea, or coffee cuts the risk of diabetes by 14%. Replacing a serving of a sweetened milk beverage with either of the three reduces the risk by 20-25%.
The study also showed that for each 5% of higher intake of energy from total sweet beverages was linked with an 18% increased risk for diabetes.
The researchers determined that if participants had decreased the energy they obtained from sweet beverages to below 2% of total daily energy, 15% of new diabetes cases could be avoided.
"Our new findings on the potential to reduce the burden of diabetes by reducing the percentage of energy consumed from sweet beverages add further important evidence to the recommendation from the World Health Organization to limit the intake of free sugars in our diet," lead researcher Dr. Nita Forouhi, of the UK Medical Research Council Epidemiology Unit, University of Cambridge, said.
Replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|